Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease

Ilana van Rensburg (Cape Town, South Africa), Ilana van Rensburg, Andre Loxton

Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Session: Active and latent tuberculosis: biomarkers
Session type: Poster Discussion
Number: 2113
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ilana van Rensburg (Cape Town, South Africa), Ilana van Rensburg, Andre Loxton. Utility of mycobacterium tuberculosis Rv0081-specific host gene expression to distinguish latent infection from active tuberculosis disease. Eur Respir J 2016; 48: Suppl. 60, 2113

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


CD27 expression as a new tool to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015


Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


Serum cytokines level can differentiate active pulmonary tuberculosis from latent TB
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013


Combined phenotypical and functional analysis of M. tuberculosis specific immunity for diagnosing active infection and risk assessment in latently infected individuals
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014

Cytokine gene polymorphisms and mycobacterium tuberculosis: from infection to pulmonary disease
Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection
Year: 2006


Glycopeptidolipids for evaluating the role of non-tuberculous mycobacteria in latent tuberculosis infection diagnosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013


Unique cytokine profiles of CD4+T cell to Acr, HBHA and MDP-1 antigens in different clinical stage of mycobacterium tuberculosis infection
Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection
Year: 2014

Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011

Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

Biomarkers of systemic inflammatory response in patients with tuberculosis, combined with HIV infection
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Pan-genomic and immunomic identification of novel mycobacterium tuberculosis antigens for TB diagnosis
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015

Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2011; 38: 1238-1239
Year: 2011


Evaluation of IFNgamma release assays for detection of cellular immunity towards M. tuberculosis and CMV in samples from deceased donors
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013

Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2011; 38: 1237-1238
Year: 2011


Markers of cellular immunity in the diagnosis of tuberculosis pleurisy
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016


Differential microRNA expression in plasma of patients with pulmonary tuberculosis
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015

Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015

Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012